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Abstract:                
Chlamydia trachomatis is an obligate intracellular pathogen that is responsible for the highest 
number of reported cases of sexually transmitted infections. Until recently Chlamydia has 
been genetically intractable, thereby limiting genetic approaches. Unfortunately, gene 
inactivation by TargeTron or antibiotic cassette insertion can result in polar effects of 
neighboring genes making it difficult to study the genes within operons. This study focuses 
on developing a novel knockdown strategy by expressing the reverse complement specific 
Chlamydia genes on a shuttle plasmid. Once cloned, the plasmids are transformed back into 
Chlamydia and the genes expressed in trans will be transcribed and bind the RNA of the 
corresponding gene producing double stranded RNA which is degraded. This method will 
allow us to look at individual genes in an operon without the polar effects of mutations. This 
strategy is being used on an operon containing 6 genes. After the reverse complement of each 
gene is expressed, the decreased expression of the target gene will be assessed by reverse 
transcription PCR. These experiments are the first to utilize a gene specific knockdown 








Introduction:          
Chlamydia trachomatis Background 
Chlamydia trachomatis is an obligate intracellular pathogen that is commonly 
sexually transmitted among humans (Elwell et al., 2016). In fact, it is the most commonly 
reported sexually transmitted disease in the United States with an estimated three million 
Chlamydia infections each year (CDC). The vast majority of these infections, almost two-
thirds of them, are found in the age group of 15-24 years with an estimated one in every 20 
women in this group being infected (CDC). With the local population being a significant 
percentage of this highly infected age group, the effects of this easily transmittable disease 
are seen in this community.  
Of the approximately three million infected people, only about one half have been 
found to seek treatment because Chlamydia infections are often asymptomatic (Newman et 
al. 2015). Due to the lack of symptoms, the statistics regarding Chlamydia infections are 
much lower than the actual incidence number of infections that occur. The lack of education 
on sexually transmitted infections and safe sex practices contribute to the high rate of 
infection, especially among young adult women (Newman et al. 2015). The stigma that 
surrounds sexually transmitted infections as well as the lack of symptoms in a large number 
of Chlamydia infections often leads individuals to neglect seeking treatment for their 
infections for long periods of time. Many who are unaware of an infection due to it being 
asymptomatic will not ever receive treatment unless they regularly get tested for sexually 
transmitted diseases. Many males are carriers of asymptomatic Chlamydia and pass their 







disease (CDC). Untreated infections can have short and long-term negative consequences. 
However, even after antibiotic treatment and clearance of the infection, long term health 
problems such as pelvic inflammatory disease, scarring of the fallopian tubes, tubal factor 
infertility and ectopic pregnancies (Bakken et al. 2007)  are still of great concern (Low et al. 
2006). It is currently unknown what the cause of these long-term health effects are which is 
why research must continue to be done on the topic. With the high rate of infectivity and the 
lack of education on the spreading of sexually transmitted infections, it is pertinent that 
research continue to be done to find the cause of these long-term effects in order to find 
options to treat and potentially prevent them.  
For decades Chlamydia trachomatis was genetically intractable which made 
deciphering the role of specific genes in pathogenesis difficult (Heuer et al. 2007). Within the 
last five years, new advancements have led to multiple mechanisms to introduce gene 
mutations by allelic exchange or TargeTron insertion (Johnson and Fisher 2013). The 
problem with such mutations is that they insert a large piece of DNA into the gene of interest 
to inactivate it and this can cause polar effects on the expression of neighboring genes 
(Mueller 2016). This is highly problematic with Chlamydia since it has a highly reduced 
genome and most genes are found in operons.  As such, the goal of this project was to 
develop a genetic knockdown system that could be transformed into Chlamydia to block 
transcription of specific genes without creating a mutant strain. 
The initial goal of this project was to clone six Chlamydial genes from a specific 
operon that is only found in human pathogenic strains of Chlamydia into a shuttle vector 
(Lutter et al. 2012), a plasmid that is a fusion of a Chlamydia plasmid and an E. coli plasmid 







order to produce an mRNA transcript that will bind to the mRNA produced in the bacterial 
genome (Ji et al. 2014, Tierney& Lamour, 2005). The result would be that the newly 
introduced reverse complement mRNA would bind to the genomic mRNA resulting in 
double stranded mRNA that would be degraded. This would decrease expression of the gene 
of interest. This method will allow us to look at individual genes in an operon without the 
polar effects of mutations. These experiments will be the first to utilize a gene specific 









Methods:           
PCR primers were designed to amplify each gene in the reverse complement.  This 
means that the forward primer was designed to the complementary strand (- strand) at the end 
of the gene and the reverse primer was designed to the reading strand (+ strand) at the start of 
the gene.  Each PCR product generated the reverse complement of each gene that would be 
cloned into the shuttle vector pBOMB-Tet-mCherry (Bauler and Hackstadt 2014).  This 
plasmid allows us to clone constructs in E. coli and then transfer the final plasmid into 
Chlamydia for expression studies. The vector map and multiple cloning site for pBOMB-Tet-
mCherry is shown in Figure 1 and the primers used are seen in Table 1.  
 
 
Table 1: Primers used in this study 
Gene Primer sequence 5’→3’ Restriction site 
CT226 AAAGCGGCCGCCCTACAGACTTTCTTCCAATACAC Not 1 
CT226 AAACTGCAGATGTTTAATATTTCTTTTTGTTG Pst1 
CT228 AAAGCGGCCGCCTAAGAAGCTTGGTTAGCGTC Not 1 
CT228 AAACTGCAGATGAGTACTACTATTAGCGG Pst1 
CT229 TTTGCGGCCGCTTATTTTTTACGACGGGATGC Not1 








Of the 6 genes in the CT229-CT224 operon, we focused on CT226, CT227 and CT229 
for amplification and cloning. Primers to the other genes were designed and experiments on 
those genes would continue once the first 3 genes were done. The reason these genes were 
chosen is that they either have a function identified in lab or have functions published.  In our 
lab, CT226 protein interacts with flightless homologue 1 (FLII), however, the overall 
function has not yet been determined (Sah and Lutter, unpublished). CT228 protein interacts 
with MYPT1 to regulate the mechanism of Chlamydial host cell exit (Lutter et al. 2013) and 
CT229 protein interacts with RAB4A (Rzomp et al. 2006). A schematic representation of the 
genes in the CT229-CT224 operon with their primer location is shown in Figure 2, below. 
 
For PCR the following protocol was used for each gene. The PCR mix contains a 
combination of 25 microliters of DreamTaq Master Mix 2X, 1 microliter of the forward 
primer as described above, 1 microliter of the reverse primer as described above, 1 microliter 
of the template Chlamydia DNA, and 22 microliters of purified water to create a total of 50 
microliters of solution. The solution was then amplified by PCR under the following 
conditions: initial denaturation was performed for 1 cycle at 95° C for 3 minutes, 
denaturation was performed for 40 cycles at 95° C for 30 seconds per cycle, annealing was 
performed for 40 cycles at 52° C for 30 seconds per cycle, extension was performed for 40 
cycles at 72° C for 1 minute per cycle, and final extension was performed for 1 cycle at 72° 
Figure 2. Schematic representation of the CT229-CT224 operon and primer locations. Gene are 
shown approximate to actual size with the location of forward primers (green) and reverse 







C for 15 minutes. To ensure correct amplification, each of the PCR products were run on an 
agarose gel at 115V for 30 minutes. The images were then exposed to an ultraviolet light on a 
low setting in order to visualize the DNA fragments. This allowed the identification of the 
genes by ensuring their location on the agarose gel was consistent with the proper length of 
the intended gene. Once the PCR products were identified as being in the correct position on 
the gel, each gene proceeded to the restriction digestion and purification steps.  
Initially, we used the restriction sites and enzymes Kpn1 and Not1. The pBOMB-Tet-
mCherry vector was cut with the same primer specific restriction digest at restriction sites 
Kpn1 and Not1. The restriction digest procedure is as follows: 10 microliters of the plasmid 
DNA, 10 microliters of the CutSmart buffer, 1 microliter of the restriction enzymes Not1 and 
Kpn1, all combined with 78 microliters of water put into a 37°C water bath overnight. The 
vector was treated with Antarctic Phosphatase to remove any phosphate groups from the ends 
of the DNA in order to prevent any religation of the vector to itself if any of it was only cut 
with one restriction site instead of both. Each of the genes were also purified by the Zymo 
Research DNA Clean & Concentrator kit and eluted in 25 microliters of water. The cells 
were then ligated and transformed into Escherichia coli DH5α cells. The ligation process 
began by combining 5.5 microliters of the quick ligase buffer, 1 microliter of the vector, 4 
microliters of each of the PCR products, individually, and 0.5 microliters of the quick ligase 
enzyme. They were then mixed and left sitting at room temperature for 30 minutes. To 
transform these ligation products, 250 microliters of DH5α cells were thawed on ice and then 
combined with 5.5 microliters of the ligation products. This mixture then sat on ice for 30 
minutes. They were then heat shocked at 42°C for 30 seconds and then returned to sitting on 







were shaken in the 37°C incubator for 2 hours. The transformed cells were then grown on 
Ampicillin resistant plates to select for the cells that contained the Chlamydia gene of 
interest. After many unsuccessful attempts at cloning, new primers were designed that 
replaced the restriction sites to see if an increased compatibility with the vector resulted. The 
restriction site of Kpn1 was replaced with a restriction digest specific to restriction site Pst1 
with all other conditions remaining the same. A new vector was also generated with 
matching restriction sites for subsequent cloning reactions.  Multiple cloning reactions were 
attempted with no success.   
The strategy for the cloning procedure was altered from the initial attempt at 
directional cloning and was changed to using procedures of TOPO cloning. TOPO cloning 
allows us to sub clone a PCR amplicon directly into a plasmid, pCRTOPO 2.1.  For the 
TOPO cloning reaction freshly amplified PCR product for each gene was mixed with a salt 
solution and pCRTOPO2.1 vector for 5 min.  The mixture was transformed into E. coli 
DH5α and selected for on LB plates containing Ampicillin and X-gal. White colonies were 
repicked and each plasmid was isolated and digested with Not1 and Pst1 to verify amplicon 
insertion. The inserts were gel excised, cleaned with Zymo Research Gel Extraction kit, 
verified by gel electrophoresis and ligated into linearized pBOMB-Tet-mCherry vector. 
Ligations and transformations were performed as described above.   
Once clones were achieved, the plasmids were then prepared for sequencing through 
the Zymo Research Zippy Plasmid Midi Prep kit. The plasmids were then separated on an 
agarose gel to verify that the inserts were present in the plasmids. After confirmation of 
plasmids, they were then sent to the Biochemistry department for sequencing. After the 







transformation into Chlamydia. Chlamydia will update plasmid DNA if it is not methylated 
thus the need for methylating the plasmids. Most cloning strains produce methylated DNA, 
including our E. coli strain DH5α, so we had to transform the final plasmid products into E. 







Results:           
The reverse complement of the genes CT226, CT228, and CT229 were all 
successfully PCR amplified as described above. The results of the agarose gel electrophoresis 
of each of the PCR products of the 3 genes are visualized in Figure 3. This figure confirms 
that each of the three genes were properly amplified because the location of the band on the 
agarose gel in comparison with the DNA Ladder in lane 
1 was the expected size.  
Once the PCR products were confirmed, the vector as well as each gene underwent 
restriction digestion through the above mentioned procedure. The vector was then cleaned 
using a gel purification procedure to remove the nucleotides, enzymes, and salts from the 
solution which could interfere with subsequent reactions. Each of the genes were cleaned 
with the Zippy DNA Clean Up Kit as previously mentioned. The digested and cleaned vector 
and genes were then visualized by agarose gel electrophoresis. This provided evidence that 
the initially circular vector was properly cut and linearized due to its appearance as a single 
band in Figure 4. This gel also provided proof of each of the genes being recovered after the 
cleaning procedures by showing they are in the same position on the gel in Figure 4 as they 
were in Figure 3. Once the vector was seen to be linearized and it was confirmed that the 
genes were successfully recovered after the cleaning procedure, the genes were then TOPO 
cloned into the vector using the method described above. To differentiate between the cells 
Figure 3. PCR amplification of CT226, CT228 and CT229. 
The first lane of this figure shows a 1Kb ladder followed by the 
initial PCR products of the reverse complement of the genes 







that successfully inserted the Chlamydia DNA and those that did not, a blue and white 
selection procedure was used. The white colonies represented in Figure 5 below are the 
successfully cloned cells and were subsequently picked from the plates and grown in a broth 
culture. The blue colonies show the cells in which Chlamydia genes did not successfully 
insert and therefore were not picked from the plate. The image in Figure 5 is an example of 
what a blue white selection test looks like as all of the white colonies on the plates used in 










Figure 4. Electrophoresis visualization of linearized vector 
and purified inserts for cloning reactions. The first lane of 
this figure shows a 1 Kb ladder followed by the cut, 
linearized, and purified vector pBOMB-Tet-mCherry in lane 
2. Lanes 3, 4, and 5 show the restriction digested and cleaned 
genes CT226, CT228, and CT229, respectively.  
Figure 5. Blue white screening of TOPO Cloning 
reactions. This image is an example of how blue white 
selection differentiate between the cells containing 








The white colonies that were picked from the TOPO cloning reactions were struck 
onto LB plates containing Ampicillin and incubated for about 18 hours. The cells that grew 
on these plates were then used to set up overnight broth cultures for plasmid extraction. 
Plasmids were purified, restriction digested with the enzymes Not1 and Pst1 through the 
procedure described above. All of these restriction digests were separated by agarose gel 
electrophoresis to confirm the TOPO cloning was successful. Multiple clones for each gene 
were tested and we were able to visualize which constructs were successfully TOPO cloned 
due to the presence of three distinct bands. The genes CT226, CT228, and CT229 were all 
successfully TOPO cloned and visualized in Figure 6 in lanes 5, 9, and 12, respectively as 
seen by the 
presence of three distinct bands in each of the before 
mentioned lanes. The TOPO vector also contains a 
Not1 site outside of the multiple cloning site which cuts the TOPO plasmid into 2 pieces 
which is why we look for 3 distinct bands. The third DNA fragment is our gene of interest in 
each clone. The genes were gel extracted, directionally cloned into the shuttle plasmid, and 







Figure 6. Restriction digest of TOPO Cloning 
reactions. Lane 1 contains a 1Kb ladder. Lane 2 contains 
an example of an empty TOPO cloning. Lanes 5, 9, and 
12 contain the successfully TOPO cloned genes CT226, 

















Discussion and Conclusion:     
Genetic manipulation of obligate intracellular pathogens is very challenging and each 
obligate intracellular pathogen comes with its own unique obstacles to overcome (Wood et al 
2014). Genetic work with the obligate intracellular pathogen Chlamydia is a very new and 
therefore a very difficult process. Only recently (within the last 5 years) have tools and 
techniques been developed to help researchers genetically alter Chlamydia. One tool in 
particular was the development of 3 shuttle vectors, one of which pBOMB-Tet-mCherry was 
used in this project (Bauler and Hackstadt 2014). The shuttle plasmids consist of a fusion of 
an E. coli plasmid and Chlamydia plasmid into a single plasmid. Because these plasmids 
contain E. coli and Chlamydia origins of replication they allow for us to clone genes in an E. 
coli background and then transform the resulting clones into Chlamydia. Before the ability to 
genetically transform Chlamydia and the creation of these shuttle plasmids, it was impossible 
to express any genes in trans in Chlamydia (Bauler and Hackstadt 2014). Even with the 
creation of these shuttle plasmids, the process of genetic mutation in Chlamydia is long and 
difficult. In addition, due to its small genome size and the arrangement of a majority of its 
genes in operons, genetic mutations cause polar effects on the genes surrounding the mutated 
gene making it impossible to tell the function of the individual gene (Mueller 2016). Multiple 
techniques have focused on making mutation using the TargeTron system (Johnson and 
Fisher, 2013), allelic exchange with the insertion of an antibiotic cassette to inactivate the 
target gene (Mueller et al. 2016), and even the development of CRISPR technologies that can 
be adapted to Chlamydia (Oullette 2018). However, with the development of these 







This was the basis for the development of a novel knockdown strategy. The design 
for this project was chosen based on these new advancements and in order to avoid issues 
found in other experiments. The knockdown strategy was also chosen because it will allow 
for the ability to understand the function of a single gene without any polar effects from 
neighboring genes which is the ultimate goal of this project. There are, however, many 
challenges with cloning obligate intracellular pathogens, especially those with a reduced 
genome like Chlamydia trachomatis (Elwell et al. 2016).  
To summarize the results from this study, each of the three target Chlamydial genes 
CT226, CT228, and CT229 were successfully amplified in the reverse complement and 
confirmed through agarose gel electrophoresis. The next steps of verifying if the knockdown 
strategy works well would be exciting as it would represent a very new strategy to 
manipulate Chlamydia genetically. We do, however, believe these next steps will be 
successful as similar techniques have successfully been used in other pathogens. A recent 
study in another obligate intracellular pathogen, Rickettsia rickettsi used single-stranded 
synthetic DNA that was complementary to the Shine-Dalgarno (start codon regions of the 
bacterial mRNA) to reduce protein expression from their target genes of interest (Pelc wt al 
2015).  An additional study in E. coli, looking at genes within a highly coordinated operon 
(similar to the genetic arrangement of genes in the Chlamydia genome) used the same 
approach as we did in this study to assess the function of each gene in the operon separately 
(Goh et al 2015). 
Most of the previous research on Chlamydia trachomatis dealt with Chlamydia while 







for work with Chlamydia independently from its host cell. That is why the genetic 
knockdown strategy designed for this study is novel because it only recently became a 
possibility. There are many practical applications for a genetic knockdown system in 
Chlamydia trachomatis. Since the genome is quite small (has a reduced genome) and most of 
its genes are arranged in operons, there is a good chance that a majority of the genes in the 
Chlamydia genome may be essential (Elwell et al. 2016). This knockdown strategy will 
allow for the function of each gene to individually be reduced or removed during different 
time intervals of the infection process without the need to generate a mutant. This would be 
very useful to assess genes that may be essential at different stages of the infection process. 
This will also allow for any gene in an entire operon to be removed from expression without 
having any polar effects in neighboring genes which is a huge concern when making 
Chlamydial mutants (Heuer et al. 2007). Since the expression of the genes cloned can be 
controlled via the tetracycline inducible promoter throughout the entire infectious process, 
we will be able to understand the function of each gene at any point in time.  
The ultimate goal of this study is to find which gene or genes is responsible for the 
long-term health effects that Chlamydia trachomatis infections can cause. By identifying the 
function of each gene in the CT229-CT224 operon, we will be able to see exactly how each 
gene contributes to the cause of these symptoms. This will allow for more targeted treatment 
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